1. Risk factors for doxorubicin induced congestive heart failure;DD, Von Hoff; MW, Layard; P, Basa;Ann Interim Med,1979
2. Cardiac toxicity 4 to 20 years after completing anthracycline therapy;Steinherz, I.; Steinherz, P.G.; Tan, C.T.C.; Heller, G.; Murphy, L.;JAMA,1991
3. et al Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumour response;Myers, C.E.; McGuire, P.; Liss, R.H.;Science,1977
4. Anthracycline enhanced oxygen radical formation;Doroshow, J.H.; Reeves, J.
5. Prospective evaluation of cardiotoxicity during a six hour doxorubicin infusion regime in women with adenocarcinoma of the breast;MD, Speyer J.L.Green; N, Dubin;Am gMed,1985